Complementary and alternative medicine (CAM) information and support needs of Chinese-speaking cancer patients

被引:10
|
作者
Balneaves, Lynda G. [1 ]
Wong, M. E. [2 ]
Porcino, A. J. [3 ]
Truant, T. L. O. [4 ]
Thorne, S. E. [4 ]
Wong, S. T. [4 ,5 ]
机构
[1] Univ Manitoba, Rady Fac Hlth Sci, Coll Nursing, 89 Curry Pl, Winnipeg, MB R3T 2N2, Canada
[2] Vancouver Coastal Hlth Reg, Vancouver, BC, Canada
[3] Touch Freedom Res Consulting, Vancouver, BC, Canada
[4] Univ British Columbia, Fac Appl Sci, Sch Nursing, Vancouver, BC, Canada
[5] Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC, Canada
关键词
Complementary therapies; Chinese-Canadian; Cancer; Qualitative research; Immigrants; ETHNIC-DIFFERENCES; DECISION-MAKING; BREAST-CANCER; CARE; THERAPIES; WOMEN; IMPACT; MODEL;
D O I
10.1007/s00520-018-4288-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Complementary and alternative medicine (CAM) is popular among Chinese-speaking cancer patients (CSCPs), but little research examines CAM use by Canadian CSCPs. The use of CAM is controversial because of potential interactions with conventional cancer treatments. The purpose of this study was to explore CSCPs' use of CAM, sources of CAM information, and decision support needs, as well as their experience of making CAM decisions. Methods A sequential, multi-method research design was used: a secondary data analysis of a CAM use survey conducted in a Western Canadian regional cancer agency followed by a qualitative interpretive description approach to inquiry using semi-structured interviews with CSPCs and support persons. Results More than 65% of CSCPs reported using CAM. CSCPs favored biologically-based therapies, including traditional Chinese medicine herbs and other natural health products. Many CSCPs were using CAM without adequate culturally appropriate information and decision support. Those who made decisions spontaneously relied on peers for advice whereas deliberate decision makers sought information from multiple sources, including peers and the Internet, selecting therapies congruent with their cultural health perspectives and previous experiences with CAM. CSCPs rarely spoke with oncology healthcare providers (HCPs) about CAM use. Conclusions CSCPs reported using CAM at rates significantly higher than for non-CSCPs. Given the predominance of biological-based therapies and the lack of consultation with oncology HCPs, it is imperative that CAM use be assessed and documented to ensure CSCPs' safety during cancer treatment. Culturally appropriate information and decision support is required to ensure that CSCPs are making safe and informed CAM decisions.
引用
收藏
页码:4151 / 4159
页数:9
相关论文
共 50 条